idarubicin has been researched along with Duncan Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbui, T; Bassan, R; Chiodini, B; Cornelli, PE; Cortelazzo, S; Lerede, T; Zucchetti, M | 1 |
1 trial(s) available for idarubicin and Duncan Disease
| Article | Year |
|---|---|
Short course infusional idarubicin plus intermittent cytarabine and etoposide for refractory hematologic malignancies: clinical and preliminary pharmacological results.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytarabine; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Hematologic Neoplasms; Humans; Idarubicin; Lymphoproliferative Disorders; Male; Middle Aged | 1998 |